Sanofi Proposes Appointment of New Independent Directors
By Nina Kienle
Sanofi said it would propose the appointment of new independent directors, as Diane Souza, and Thomas Suedhof intend to leave at the end of their second terms.
The French pharmaceutical company said late Thursday that it plans to propose the appointment of Clotilde Delbos, Anne-Francoise Nesmes and John Sundy as independent directors as well as the renewal of the terms of office of Rachel Duan and Lise Kingo.
Write to Nina Kienle at nina.kienle@wsj.com
(END) Dow Jones Newswires
February 23, 2024 04:59 ET (09:59 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
What’s Happening in the Markets This Week
-
4 Top Dividend-Paying REIT Stock Picks
-
After Earnings, Is Netflix Stock a Buy, a Sell, or Fairly Valued?
-
P-CAPE: A Better Way for Investors to Estimate Future Returns
-
Which Stocks Have Driven the Stealth Large-Value Rally?
-
Forecasts for Q2 GDP Report Show a Healthy but Slowing Economy
-
5 Stocks to Buy as the Market Rally Broadens
-
4 Top US Travel Stock Picks
-
How Do Interest Rates Affect Stock Market Returns?
-
American Airlines Earnings: Ticket Distribution Misstep Affected Results
-
Going Into Earnings, Is Albemarle Stock a Buy, a Sell, or Fairly Valued?
-
3 Top Cybersecurity Stock Picks for Long-Term Investors
-
AbbVie Earnings: Firm Sees Strong Next-Generation Immunology Drugs Sales
-
Ford Earnings: Warranty Problems on Older Vehicles Slam Results
-
ServiceNow Earnings: Operating on a Higher Plane Within Enterprise Software